Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Bone Disorders01:29

Bone Disorders

8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Bone Remodeling01:40

Bone Remodeling

34.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.4K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

5.1K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Economic impact of initiation of home mechanical ventilation: a budget impact analysis from the Netherlands.

BMJ open respiratory research·2026
Same author

Clinical pharmacy services for tuberculosis management: a systematic review.

Frontiers in pharmacology·2023
Same author

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Digital medication adherence technology: towards personalised TB care.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

An Inca trail to the Holy Grail: digital medication adherence support for TB care.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020

Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K

Proactive pharmaceutical care interventions decrease patients' nonadherence to osteoporosis medication.

A G G Stuurman-Bieze1, E G Hiddink, J F M van Boven

  • 1West Pharmacy, Europalaan 124, 8303 GL, Emmeloord, The Netherlands, ada@fstuurman.nl.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
|February 27, 2014
PubMed
Summary

Pharmacists can improve osteoporosis medication adherence through tailored counseling and continuous monitoring. This intervention significantly reduced discontinuation and nonadherence rates in patients starting osteoporosis treatment.

Related Experiment Videos

Last Updated: May 2, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K

Area of Science:

  • Pharmacology
  • Pharmacy Practice
  • Public Health

Background:

  • Community pharmacies are vital for osteoporosis management.
  • Pharmacists' impact on medication adherence requires further investigation.
  • Osteoporosis medication nonadherence poses a significant public health challenge.

Purpose of the Study:

  • To evaluate the effectiveness of a community pharmacist-led intervention program.
  • To assess the impact of the Medication Monitoring and Optimization (MeMO) intervention on 1-year adherence rates for osteoporosis medication.
  • To determine the effect of pharmacist intervention on therapy discontinuation and nonadherence.

Main Methods:

  • An intervention study involving 937 patients initiating osteoporosis medication across 13 Dutch community pharmacies.
  • The intervention group received continuous monitoring and tailored counseling (MeMO intervention).
  • Comparison was made against a usual pharmacy care reference group, with outcomes analyzed using Cox proportional hazard analysis.

Main Results:

  • The intervention group showed a significantly lower discontinuation and nonadherence rate (19.0%) compared to the usual care group (32.8%) (P < 0.001).
  • Patient satisfaction with pharmacy services was high (93%).
  • A notable 31% of patients identified pharmacies as their sole source of medication information.

Conclusions:

  • Community pharmacists can effectively reduce nonadherence and discontinuation of osteoporosis medications.
  • Protocolled intervention programs, like MeMO, enhance medication adherence and optimize osteoporosis treatment.
  • Continuous monitoring and tailored counseling are key components of successful pharmaceutical care for osteoporosis patients.